We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVST icon
1751
Envista
NVST
$4.66B
$18K ﹤0.01%
+639
New +$18.2K
OLN icon
1752
Olin
OLN
$2.45B
$18K ﹤0.01%
1,119
+115
+11% +$2.06K
PLXS icon
1753
Plexus
PLXS
$6.4B
$18K ﹤0.01%
241
+97
+67% +$7.04K
SBCF icon
1754
Seacoast Banking Corp of Florida
SBCF
$3.33B
$18K ﹤0.01%
591
+150
+34% +$4.26K
STC icon
1755
Stewart Information Services
STC
$2.14B
$18K ﹤0.01%
463
+206
+80% +$8.45K
THRM icon
1756
Gentherm
THRM
$1.31B
$18K ﹤0.01%
406
+100
+33% +$4.26K
UTG icon
1757
Reaves Utility Income Fund
UTG
$3.5B
$18K ﹤0.01%
502
WIRE
1758
DELISTED
Encore Wire Corp
WIRE
$18K ﹤0.01%
331
+71
+27% +$4.08K
PFXNL
1759
DELISTED
PhenixFIN Corporation 6.125% Senior Notes due 2023
PFXNL
$18K ﹤0.01%
757
NBEV
1760
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$18K ﹤0.01%
+10,000
New +$23.7K
ZNGA
1761
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$18K ﹤0.01%
3,000
MINI
1762
DELISTED
Mobile Mini Inc
MINI
$18K ﹤0.01%
475
+118
+33% +$4.45K
AGIO icon
1763
Agios Pharmaceuticals
AGIO
$2.1B
$17K ﹤0.01%
376
+349
+1,293% +$13.2K
BHE icon
1764
Benchmark Electronics
BHE
$2.63B
$17K ﹤0.01%
514
+119
+30% +$3.93K
BMI icon
1765
Badger Meter
BMI
$3.81B
$17K ﹤0.01%
277
+71
+34% +$4.21K
CSGS
1766
DELISTED
CSG Systems International
CSGS
$17K ﹤0.01%
335
+72
+27% +$3.88K
CZA icon
1767
Invesco Zacks Mid-Cap ETF
CZA
$192M
$17K ﹤0.01%
233
FLS icon
1768
Flowserve
FLS
$8.96B
$17K ﹤0.01%
359
+136
+61% +$6.51K
GTX icon
1769
Garrett Motion
GTX
$5.49B
$17K ﹤0.01%
1,730
-1,930
-53% -$19.7K
KWEB icon
1770
KraneShares CSI China Internet ETF
KWEB
$5.48B
$17K ﹤0.01%
355
LTC
1771
LTC Properties
LTC
$2.14B
$17K ﹤0.01%
399
+75
+23% +$3.6K
MATW icon
1772
Matthews International
MATW
$897M
$17K ﹤0.01%
452
+157
+53% +$5.76K
OSUR icon
1773
OraSure Technologies
OSUR
$275M
$17K ﹤0.01%
2,244
SIG icon
1774
Signet Jewelers
SIG
$3.78B
$17K ﹤0.01%
822
+414
+101% +$7.35K
SIGI icon
1775
Selective Insurance
SIGI
$5.65B
$17K ﹤0.01%
271
-65
-19% -$4.5K

Similar funds

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.